Neopharm Reports Operating Profit of 21.9 Billion KRW Last Year, Down 4.6% Year-on-Year

[Asia Economy Reporter Seungjin Lee] Neopharm announced on the 8th that its consolidated operating profit for last year was tentatively estimated at 21.9 billion KRW, a 4.6% decrease compared to the previous year.

Sales amounted to 81.6 billion KRW, down 1.9% from the previous year. Net profit decreased by 7.2% to 17.8 billion KRW.

Operating profit for the 4th quarter was 6.6 billion KRW, up 16.9% year-on-year, while sales and net profit were 23 billion KRW and 5 billion KRW, respectively.